Introduction
============

Recent attention has focused on discovering new biomarkers that may serve as indicators of both health span and life span. DNA methylation, telomere erosion, DNA damage and repair, mitochondrial copy number and function are considered markers of biological aging \[[@r1]\]. However, it has been difficult to unequivocally identify a single universal biomarker to monitor aging differentiated from disease because there is considerable variation in the signs and symptoms of aging. Studies have also identified noncoding RNAs (ncRNAs), such as microRNAs (miRNAs), as relevant biomarkers of aging. We and others have shown that miRNA levels change during human aging \[[@r2]--[@r6]\]. Interestingly, these changes in miRNA levels can be modulated by interventions such as calorie restriction or metformin \[[@r7],[@r8]\]. miRNAs are also key regulators of cellular processes important for aging such as cellular senescence \[[@r2]\]. Data from model systems also support a role for miRNAs in the aging process. For example, the *Caenorhabditis elegans* miRNA *lin-4* regulates lifespan through modulating expression of its target gene, *lin-14* \[[@r9]\]. Since this initial discovery several other miRNAs have been associated with regulating longevity in *C. elegans* \[[@r10]\].

Most recently, increasing interest in another class of ncRNAs, long ncRNAs (lncRNAs), has gained momentum as these molecules can also regulate gene expression at the transcriptional, post-transcriptional and translational levels \[[@r11],[@r12]\]. Furthermore, lncRNAs have been linked to processes important for aging and age-related disease \[[@r13]--[@r15]\]. However, little is known about the global changes in lncRNA expression that occur with aging. Aging is a multi-factorial process marked by a fundamental decline in physiological responses and maintenance of tissue homeostasis and integrity. This decline of cell, tissue and organ function leads to an increase in a myriad of age-related diseases including cancer, type 2 diabetes mellitus, autoimmunity, infections, cardiovascular disease and ultimately mortality. Recent findings from model systems suggest that longevity and health span can be modulated by specific changes in gene expression patterns \[[@r10],[@r16]\]. These patterns could be useful markers for identifying individuals in at-risk populations for the premature development of disease or monitoring adverse outcomes that may lead to early mortality.

Social determinants of health significantly influence the trajectory of aging, health status and outcomes among populations at risk for health disparities. It is well known that poverty and low socioeconomic status remain major risk factors for cardiovascular disease, chronic kidney disease and early mortality \[[@r17]--[@r19]\]. The weathering hypothesis suggests that socioeconomic disadvantage results in accelerated aging or premature declines in health status among African Americans (AAs) \[[@r20]\]. In the United States, AA men are particularly vulnerable to early mortality \[[@r21]--[@r24]\]. Therefore, it is important to identify the biological mechanisms and biologic risk factors through which social determinants of health accelerate aging phenotypes and trigger premature mortality. Adverse social conditions, including poverty, poor neighborhood conditions, discrimination, and crime are robust risk factors for negative health outcomes. Social adversity has been linked to gene expression changes in both children and adults \[[@r25]--[@r27]\]. Specifically, challenging social-environmental conditions initiate changes in gene expression among specific gene sets. The observed increase in mRNAs encoding inflammatory proteins and the decrease in mRNAs encoding immune-response proteins, termed the Conserved Transcriptional Response to Adversity (CTRA) \[[@r25]--[@r27]\], has been documented in several human and non-human models (for review \[[@r28]\]). These data hint that differences in gene expression may underlie racial and socioeconomic disparities in health.

Here we profiled both lncRNAs and mRNAs in the context of human aging, race and poverty. These lncRNAs may serve as potential biomarkers of susceptibility to age-related diseases. In addition, lncRNAs may be important promoters of the change in gene expression that results from exposure to various social-environmental conditions.

RESULTS
=======

lncRNA changes with age and poverty
-----------------------------------

Although lncRNAs have been studied in the context of senescence and various other hallmarks of aging, little is known about whether lncRNA expression is altered with human age. Furthermore, since poverty is well known to influence accelerated development of age-associated chronic disease and premature mortality \[[@r29],[@r30]\], we chose a sub-cohort of young and old AAs and whites from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study that were both below and above poverty ([Table 1](#t1){ref-type="table"}). Poverty was designated as below poverty if the self-reported household income was below 125% of the 2004 Health and Human Services Poverty Guidelines at baseline recruitment. For our initial assessment of lncRNAs, we used the Arraystar human lncRNA microarray V3.0, which profiles about 30,586 lncRNAs and 26,109 coding transcripts. We selected young (30.6 yrs) and old males (63.3 years) that were either white or AA both below or above poverty (n=8/group [Table 1](#t1){ref-type="table"}).

###### Demographic information for human cohorts.

  ------------------------ ------------ ------------
  **Microarray cohorts**                
  **White males**          **Young**    **Old**
  n                        8            8
  Age (mean(SD))           30.6 (0.5)   63.6 (0.5)
  PovStat = Below (%)      3 (37.5)     4 (50)
                                        
  **AA males**             **Young**    **Old**
  n                        8            8
  Age (mean(SD))           30.6 (0.5)   63.5 (0.5)
  PovStat = Below (%)      4 (50)       4 (50)
                                        
                                        
  **Validation cohort**                 
  **White males**          **Young**    **Old**
  n                        20           20
  Age (mean(SD))           32.1 (1.7)   62.6 (1.2)
  PovStat = Below (%)      9 (45)       9 (45)
  ------------------------ ------------ ------------

We found that a substantial number of lncRNAs were significantly altered with human age in white males (1938 lncRNAs; [Figure 1A](#f1){ref-type="fig"}; [Supplementary Table 1](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD3){ref-type="supplementary-material"}). In addition, poverty status also significantly changed the levels of lncRNAs in white males (1807 lncRNAs; [Figure 1B](#f1){ref-type="fig"}; [Supplementary Table 3](#SD4){ref-type="supplementary-material"}, [Supplementary Table 4](#SD5){ref-type="supplementary-material"}). The top changes in lncRNA abundance with age and poverty are listed in [Tables 2 and 3](#t2){ref-type="table"}[](#t3){ref-type="table"}, respectively and shown in the heat maps in [Figure 1C](#f1){ref-type="fig"}. A list of all significantly altered lncRNAs with age and poverty are found in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD3){ref-type="supplementary-material"}, [Supplementary Table 3](#SD4){ref-type="supplementary-material"}, [Supplementary Table 4](#SD5){ref-type="supplementary-material"}. Intriguingly, lncRNA changes with poverty were not observed in young individuals, but were robust among old individuals, consistent with the idea that poverty over the life span may greatly influence gene expression ([Figure 1D](#f1){ref-type="fig"}). However, we did not assess childhood poverty or socioeconomic status. Comparison of the lncRNAs changed in abundance between poverty and age indicate that 1,029 lncRNAs that were significantly altered overlap with poverty and age ([Figure 1E](#f1){ref-type="fig"}). We observed a different pattern for lncRNA differences with poverty and age in AA males ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}), where far fewer lncRNAs were significantly changed in abundance with age (only 26) and with poverty (245).

![**Changes in lncRNA abundance with age and poverty.** The lncRNA expression levels in white young and old males (**A**) living above or below poverty (**B**) were assessed using microarrays ([Table 1](#t1){ref-type="table"} for demographic details). Volcano plots show log2 fold change and *P* value for each lncRNA. Red indicates lncRNAs that were [\>]{.ul}2-fold change and *P*[\<]{.ul}0.05. (**A**,**B**,**D**) lncRNA comparisons between groups are indicated. (**C**) Heat maps indicate the top fold changed lncRNAs with age and poverty. These lncRNAs are also listed in [Tables 2 and 3](#t2){ref-type="table"}[](#t3){ref-type="table"}. (**E**) Venn diagram of the total number of significantly increased or decreased lncRNAs for each comparison. Y, young; O, old, AP, above poverty; BP, below poverty.](aging-11-101823-g001){#f1}

###### Top changes in lncRNA abundance with age.

  ------------------------ ------------------------ --------------- ----------------- ------------------------ ----------------------------- ---------- --------------- ------------------------ ------------------------
  **Increased in Young**   **Decreased in Young**                                                                                                                                                
  **Gene Symbol**          **Fold**                 ***P* value**   **Seqname**       **Source**               **Gene Symbol**               **Fold**   ***P* value**   **Seqname**              **Source**
  ***CTD-3247F14.2***      18.50                    0.008           ENST00000566457   GENCODE                  ***KB-1047C11.2***            37.34      0.000           ENST00000517655          GENCODE
  ***AK027145***           10.52                    0.001           uc002ywy.3        UCSC_knowngene           ***XLOC_002730***             31.53      0.016           TCONS_00006917           LincRNAs; Cabili et al
  ***RP5-826L7.1***        10.14                    0.002           ENST00000446476   GENCODE                  ***RP11-573D15.9***           27.85      0.000           ENST00000577781          GENCODE
  ***SDHAP1***             9.57                     0.000           ENST00000440850   pseudogene               ***RP11-479J7.2***            27.24      0.002           ENST00000425271          GENCODE
  ***RP11-773D16.1***      8.94                     0.000           ENST00000496359   GENCODE                  ***XLOC_008375***             26.51      0.002           TCONS_00018115           LincRNAs; Cabili et al
  ***DIP2A-IT1***          8.67                     0.002           NR_046400         RefSeq                   ***LOC400456***               22.55      0.001           NR_034095                RefSeq
  ***CTD-3074O7.5***       8.47                     0.001           ENST00000533502   GENCODE                  ***XLOC_008058***             22.39      0.001           TCONS_00017457           LincRNAs; Cabili et al
  ***RP11-773D16.1***      7.60                     0.003           ENST00000488805   GENCODE                  ***KCNIP4-IT1***              21.32      0.002           NR_002813                RefSeq
  ***RP4-803J11.2***       7.46                     0.005           ENST00000418348   GENCODE                  ***AC018730.4***              21.06      0.001           ENST00000454183          GENCODE
  ***LOC100507217***       7.39                     0.011           NR_037600         RefSeq                   ***XLOC_004069***             20.96      0.001           TCONS_00008575           LincRNAs; Cabili et al
  ***BC079832***           7.16                     0.000           uc003nhj.3        UCSC_knowngene           ***chr10:7584675-7594825***   18.28      0.002           chr10:7584675-7594825-   LincRNAs; Cabili et al
  ***LINC00085***          7.10                     0.003           ENST00000573896   GENCODE                  ***XLOC_002730***             18.03      0.008           TCONS_00006916           LincRNAs; Cabili et al
  ***RP11-510J16.3***      6.89                     0.013           ENST00000564138   GENCODE                  ***XLOC_011730***             17.92      0.000           TCONS_00024847           LincRNAs; Cabili et al
  ***RP13-582O9.5***       6.83                     0.001           ENST00000521207   GENCODE                  ***LOC100132111***            17.58      0.002           NR_024237                RefSeq
  ***RP11-1007O24.3***     6.64                     0.005           ENST00000565181   GENCODE                  ***XLOC_005939***             17.49      0.002           TCONS_00011248           LincRNAs; Cabili et al
  ***XLOC_003262***        6.59                     0.023           TCONS_00006666    LincRNAs; Cabili et al   ***MBL1P***                   17.35      0.002           ENST00000480805          GENCODE
  ***RP11-473M20.14***     6.55                     0.000           ENST00000575139   GENCODE                  ***HMlincRNA152***            16.72      0.002           HMlincRNA152-            LincRNAs; Cabili et al
  ***XLOC_008382***        6.53                     0.000           TCONS_00018121    LincRNAs;Cabili et al    ***XLOC_000781***             16.36      0.000           TCONS_00001451           LincRNAs; Cabili et al
  ***WBSCR22***            6.52                     0.008           NR_037776         RefSeq                   ***RP11-281A20.1***           16.34      0.002           ENST00000449730          GENCODE
  ***FJ009034***           6.41                     0.001           uc010wyg.2        UCSC_knowngene           ***RP11-525K10.3***           16.31      0.001           ENST00000568776          GENCODE
  ------------------------ ------------------------ --------------- ----------------- ------------------------ ----------------------------- ---------- --------------- ------------------------ ------------------------

Top lncRNAs differentially expressed with age and *P*\<0.05, Fold change \>2 and FDR \<0.1.

###### Top changes in lncRNA abundance with poverty.

  -------------------------------- -------------------------------- --------------- ----------------- ------------------------ ----------------------------- ---------- --------------- ------------------------ ------------------------
  **Increased in Above Poverty**   **Decreased in Above Poverty**                                                                                                                                                
  **Gene Symbol**                  **Fold**                         ***P* value**   **Seqname**       **Source**               **Gene Symbol**               **Fold**   ***P* value**   **Seqname**              **Source**
  ***D63785***                     15.93                            0.006           uc002hlt.1        UCSC_knowngene           ***AK022914***                9.82       0.003           uc001vvr.1               UCSC_knowngene
  ***CTD-3247F14.2***              12.74                            0.028           ENST00000566457   GENCODE                  ***LOC400456***               9.41       0.039           NR_034095                RefSeq
  ***XLOC_003262***                9.13                             0.006           TCONS_00006666    LincRNAs; Cabili et al   ***chr10:7584675-7594825***   8.88       0.036           chr10:7584675-7594825-   LincRNAs; Cabili et al
  ***RP11-143M1.2***               9.02                             0.022           ENST00000442069   GENCODE                  ***LA16c-390E6.5***           8.81       0.006           ENST00000566287          GENCODE
  ***RP1-283E3.4***                8.86                             0.006           ENST00000577672   GENCODE                  ***AC108142.1***              8.39       0.048           ENST00000507869          GENCODE
  ***AC092620.3***                 8.23                             0.004           ENST00000453636   GENCODE                  ***BC007940***                8.22       0.038           uc002xzq.1               UCSC_knowngene
  ***RP11-510J16.3***              8.15                             0.006           ENST00000564138   GENCODE                  ***LINC00426***               8.17       0.001           ENST00000447147          GENCODE
  ***RP11-622K12.1***              8.05                             0.003           ENST00000423617   GENCODE                  ***RP11-19P22.5***            8.14       0.017           ENST00000583179          GENCODE
  ***RPL18***                      7.91                             0.003           NR_073022         RefSeq                   ***AC093391.2***              8.01       0.016           ENST00000446492          GENCODE
  ***CTD-2576F9.2***               7.55                             0.003           ENST00000568835   GENCODE                  ***XLOC_007703***             8.01       0.032           TCONS_00016773           LincRNAs; Cabili et al
  ***CTC-338M12.4***               7.04                             0.006           ENST00000506340   GENCODE                  ***OSTCP1***                  7.70       0.005           ENST00000522287          GENCODE
  ***LOC550643***                  6.54                             0.005           NR_015367         RefSeq                   ***SMCR2***                   7.56       0.025           ENST00000456090          GENCODE
  ***RP5-826L7.1***                6.39                             0.024           ENST00000446476   GENCODE                  ***RP11-10N23.2***            7.38       0.008           ENST00000520562          GENCODE
  ***RNASEK***                     6.35                             0.001           NR_037715         RefSeq                   ***AC004562.1***              7.27       0.024           ENST00000420427          GENCODE
  ***RAC1P2***                     6.26                             0.003           ENST00000511164   pseudogene               ***RP11-175K6.1***            7.26       0.027           ENST00000523301          GENCODE
  ***WBSCR22***                    6.01                             0.013           NR_037776         RefSeq                   ***AC098973.2***              7.21       0.019           ENST00000414382          GENCODE
  ***LOC100507217***               6.00                             0.028           NR_037600         RefSeq                   ***AK130076***                7.17       0.039           uc001kfc.1               UCSC_knowngene
  ***RNASEK-C17ORF49***            5.81                             0.002           NR_037717         RefSeq                   ***RP11-378J18.5***           6.96       0.011           ENST00000433391          GENCODE
  ***RPL6P27***                    5.66                             0.007           ENST00000583065   GENCODE                  ***RP11-558A11.3***           6.91       0.040           ENST00000568458          GENCODE
  ***LSM1***                       5.65                             0.002           NR_045493         RefSeq                   **XLOC_005590**               6.898      0.035           TCONS_00012060           LincRNAs; Cabili et al
  -------------------------------- -------------------------------- --------------- ----------------- ------------------------ ----------------------------- ---------- --------------- ------------------------ ------------------------

Top lncRNAs differentially expressed with poverty and *P*\<0.05, Fold change \>2 and FDR \<0.1.

To determine the effects of race on lncRNA expression, we compared lncRNAs that were altered by race. We found that 291 lncRNAs were altered between white and AA males. Furthermore, if we categorize based on race, poverty and age, we identified changes in lncRNA levels that occurred with both races comparing above and below poverty status. There were 12 lncRNAs that were altered with poverty in both races and these are indicated in gray boxes in [Figure 2](#f2){ref-type="fig"}. Only one lncRNA, *RNF157-AS1*, changed significantly with age in both whites and AAs, and one lncRNA, *C6orf3,* changed significantly with both poverty and age in AAs ([Figure 2A](#f2){ref-type="fig"}).

![**Comparison of lncRNA level changes with age, poverty and senescence.** (**A**) Significantly changed lncRNA abundance was compared between African American (AA) males living below poverty (BP) and above poverty (AB) to white males (W) living below and above poverty. (**B**) Changes in lncRNAs levels in whites with poverty and age were also compared to significantly changed senescence-associated lncRNAs (SAL-RNAs) identified previously \[[@r31]\]. The comparisons in (**A**) were done using the Seqname and (**B**) using Gene symbol, hence the slight differences in numbers. Arrows indicate the direction of change (higher or lower) in the comparisons. The color of the arrow indicates the comparison examined.](aging-11-101823-g002){#f2}

Comparison to age-associated lncRNAs
------------------------------------

Aging and poverty associated changes in lncRNA levels in whites were also compared to lncRNAs that have previously been described in the literature to be age-associated. Since senescent cells accumulate with age, and have been linked to a number of age-related pathologies, we first compared our dataset to lncRNAs that previously were found to be significantly changed in abundance during cellular senescence, termed senescence-associated lncRNAs (SAL-RNAs) \[[@r31]\]. Several poverty-associated lncRNAs (14) and aging-related lncRNAs (13) overlapped with the various SAL-RNAs ([Figure 2B](#f2){ref-type="fig"}). There were 10 SAL-RNAs that overlapped with both comparisons ([Figure 2B](#f2){ref-type="fig"}).

We also further compared the lncRNAs we found to be significantly different to previously reported age-associated lncRNAs. These lncRNAs were compiled based on the regulation of various hallmarks of aging \[[@r13]\] or age-associated functions, including differences with aging in the achilles tendon \[[@r32]\], specific lncRNAs associated with regulating senescence \[[@r33],[@r34]\], mouse premature aging and muscle wasting \[[@r35]\]. This list consisted of 118 "Age-associated lncRNAs" ([Supplementary Table 5](#SD6){ref-type="supplementary-material"}). Three lncRNAs were overlapping between these Age-associated lncRNAs and our poverty and aging lncRNAs and three were overlapping just with poverty and four just with age ([Figure 3A](#f3){ref-type="fig"}).

![**Validation of age and poverty associated level changes in lncRNAs abundance.** (**A**) lncRNAs significantly changed in abundance with age and poverty in white males were compared to lncRNAs identified in the literature to be age-associated. Overlapping lncRNAs are shown. (**B**-**C**) RNA was isolated from PBMCs from young (mean=32.1 yrs) and old (mean=62.6 yrs) white males above and below poverty (n=40; see [Table 1](#t1){ref-type="table"} for demographics). RNA was reverse transcribed and lncRNA levels were quantified by RT-qPCR.](aging-11-101823-g003){#f3}

Validation of lncRNA changes with age and poverty
-------------------------------------------------

Several of these overlapping lncRNAs were chosen to further validate in an expanded cohort of individuals (n=40; [Table 1](#t1){ref-type="table"}). In addition, we also validated the top lncRNAs that were significantly changed in abundance with either age or poverty ([Tables 2, 3](#t2){ref-type="table"}[](#t3){ref-type="table"}). All significantly changed lncRNAs are listed in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD3){ref-type="supplementary-material"}, [Supplementary Table 3](#SD4){ref-type="supplementary-material"}, [Supplementary Table 4](#SD5){ref-type="supplementary-material"}. We designed primers for the top lncRNAs showing the most robust changes in levels and for various "Age-associated lncRNAs" including *H19, MEG3, TERC* and *GAS5*. We designed multiple primer sets for *XLOC-002730* and *LOC400456*, but we were unable to amplify these lncRNAs. We chose to further validate in the expanded cohort a total of 13 lncRNAs. *RNF157-AS1* was included since levels of this lncRNA were changed differentially with age in AAs and whites, but it was not significantly altered in this expanded cohort. Importantly, *CTD-3247F14.2 (*LNCipedia: *lnc-EGR3-1), GAS5, H19, TERC* and *MEG3* levels were all significantly changed with age ([Figure 3B](#f3){ref-type="fig"}). *AK022914 (DUXAP9),* *GAS5, KB-1047C11.2 (*LNCipedia: *C8orf37-AS1:1), MEG3* and *XLOC_003262* (LNCipedia: *lnc-KY-1*) levels were significantly different with poverty ([Figure 3C](#f3){ref-type="fig"}). Interestingly, *GAS5* binds and acts as a cytoplasmic decoy for the glucocorticoid receptor (GR) \[[@r36]\]. This observation is intriguing given that transcriptional changes in GR signaling pathways are part of the Conserved Transcriptional Response to Adversity (CTRA) in mice and humans \[[@r28]\].

mRNA changes with age and poverty
---------------------------------

In addition to examining lncRNA levels, we also wanted to further understand differences in the levels of expressed mRNAs with poverty and age. To do this, we examined mRNA expression levels by microarray and found that, similar to the lncRNAs, there were many significantly different mRNAs with both age and poverty in white males ([Figure 4A,B](#f4){ref-type="fig"}; [Supplementary Table 6](#SD7){ref-type="supplementary-material"}, [Supplementary Table 7](#SD8){ref-type="supplementary-material"}, [Supplementary Table 8](#SD9){ref-type="supplementary-material"}, [Supplementary Table 9](#SD10){ref-type="supplementary-material"}). The top changes in mRNA abundance with age and poverty are listed in [Tables 4 and 5](#t4){ref-type="table"}[](#t5){ref-type="table"}, respectively and shown in the heat maps in [Figure 4C](#f4){ref-type="fig"}. A list of all significantly altered mRNAs with age and poverty are found in [Supplementary Table 6](#SD7){ref-type="supplementary-material"}, [Supplementary Table 7](#SD8){ref-type="supplementary-material"}, [Supplementary Table 8](#SD9){ref-type="supplementary-material"}, [Supplementary Table 9](#SD10){ref-type="supplementary-material"}. Changes in expressed mRNAs with poverty were also more robust in the older individuals compared to the younger individuals, similar to our results with lncRNAs ([Figure 4D](#f4){ref-type="fig"}). Many of the differentially abundant mRNAs were overlapping between poverty and age ([Figure 4E](#f4){ref-type="fig"}). Interestingly, comparison of the top mRNAs that were more abundant in both young individuals and those living above poverty showed that out of the top 20 hits 6 overlapped including *IL1B, EIF1AY, CCL3L3, FAM96A, HLA-DRB1,* and *ATRAID* ([Figure 4C](#f4){ref-type="fig"}; [Tables 4, 5](#t4){ref-type="table"}[](#t5){ref-type="table"}). Out of the top 20 mRNAs that were less abundant with age and poverty status *ETS1, C20orf152, NANOG,* and *SLC18A3* were all overlapping ([Figure 4C](#f4){ref-type="fig"}; [Tables 4, 5](#t4){ref-type="table"}[](#t5){ref-type="table"}).

![**Changes in mRNA expression levels with age and poverty.** The levels of expressed mRNAs in white young and old males (**A**) living above or below poverty (**B**) were assessed using microarrays. Volcano plots show log2 fold change and *P* value for each mRNA. Red indicates mRNAs that changed were [\>]{.ul}2-fold, with *P*[\<]{.ul}0.05. (**A**,**B**,**D**) Comparisons of significantly different mRNAs between groups are indicated. (**C**) Heat maps indicate the top fold changed mRNAs with age and poverty. These mRNAs are also listed in [Tables 4 and 5](#t4){ref-type="table"}[](#t5){ref-type="table"}. (**E**) Venn diagram of the total number of significantly increased or decreased mRNAs for each comparison. Y, young; O, old, AP, above poverty; BP, below poverty](aging-11-101823-g004){#f4}

###### Top changes in mRNA abundance with age.

  ------------------------ ------------------------
  **Increased in Young**   **Decreased in Young**
  ------------------------ ------------------------

  **Gene Symbol**   **Fold**   ***P* value**   **Seqname**       **Gene Symbol**   **Fold**   ***P* value**   **Seqname**
  ----------------- ---------- --------------- ----------------- ----------------- ---------- --------------- -----------------
  ***IL1B***        13.23      0.027           NM_000576         ***CSMD2***       30.48      0.002           ENST00000241312
  ***EIF1AY***      12.58      0.027           ENST00000361365   ***PLCD3***       25.30      0.000           NM_133373
  ***CCL3L3***      11.02      0.009           NM_001001437      ***KRTAP9-9***    24.11      0.003           ENST00000394008
  ***FAM216A***     10.80      0.002           NM_013300         ***KRTAP9-4***    19.41      0.002           NM_033191
  ***FGFBP2***      10.32      0.002           NM_031950         ***C20orf78***    17.73      0.003           NM_001242671
  ***FAM96A***      9.42       0.003           NM_001014812      ***C4orf26***     14.59      0.000           NM_178497
  ***HIGD2A***      9.33       0.003           NM_138820         ***LRR1***        14.36      0.000           NM_203467
  ***TPI1***        8.50       0.000           NM_000365         ***PARP16***      14.22      0.001           NM_017851
  ***CLEC4D***      8.46       0.004           NM_080387         ***ZNF442***      14.17      0.002           NM_030824
  ***SPTLC2***      7.95       0.001           NM_004863         ***CABLES1***     13.31      0.005           NM_138375
  ***HLA-DRB1***    7.93       0.014           NM_002124         ***IFIT3***       11.77      0.002           NM_001549
  ***TBXAS1***      7.89       0.018           NM_001166254      ***ETS1***        11.35      0.018           NM_005238
  ***COMMD3***      7.84       0.000           NM_012071         ***CR1***         11.21      0.004           NM_000651
  ***TXN***         7.63       0.000           NM_003329         ***C20orf152***   10.51      0.002           ENST00000349339
  ***ATRAID***      7.63       0.020           NM_016085         ***NANOG***       9.89       0.005           NM_024865
  ***XRCC5***       7.45       0.016           NM_021141         ***SLC18A3***     9.55       0.003           NM_003055
  ***AP1M1***       7.41       0.000           ENST00000291439   ***ADCY6***       9.17       0.004           NM_015270
  ***PDXK***        7.21       0.005           NM_003681         ***HOXC4***       8.89       0.000           ENST00000430889
  ***ERH***         7.15       0.000           NM_004450         ***KRTAP2-4***    8.60       0.002           NM_033184
  ***GSTO1***       7.03       0.004           NM_001191003      ***DKK1***        8.56       0.002           NM_012242

Top mRNAs differentially expressed with age and *P*\<0.05, Fold change \>2 and FDR \<0.1.

###### Top changes in mRNA abundance with poverty.

  **Increased in Above Poverty**   **Decreased in Above Poverty**                                                                                  
  -------------------------------- -------------------------------- --------------- ----------------- ----------------- ---------- --------------- -----------------
  **Gene Symbol**                  **Fold**                         ***P* value**   **Seqname**       **Gene Symbol**   **Fold**   ***P* value**   **Seqname**
  ***EIF1AY***                     16.03                            0.014           ENST00000361365   ***ETS1***        11.59      0.018           NM_005238
  ***IL1B***                       14.94                            0.020           NM_000576         ***AMMECR1L***    8.72       0.006           NM_031445
  ***CST7***                       11.06                            0.004           ENST00000480798   ***CDC14B***      8.02       0.011           NM_003671
  ***HLA-DQB1***                   10.06                            0.003           NM_002123         ***DDR1***        7.64       0.005           NM_001954
  ***ATRAID***                     9.66                             0.008           NM_016085         ***NANOG***       7.34       0.021           NM_024865
  ***TREM1***                      9.46                             0.005           NM_018643         ***SOX12***       6.43       0.016           NM_006943
  ***FLJ44635***                   9.26                             0.005           NM_207422         ***MBD3L1***      6.39       0.004           ENST00000305625
  ***HLA-DRB1***                   9.05                             0.008           NM_002124         ***GTPBP3***      5.66       0.022           NM_133644
  ***SAT1***                       8.75                             0.004           NM_002970         ***SLC18A3***     5.63       0.035           NM_003055
  ***NFKBIA***                     8.73                             0.005           NM_020529         ***ZDHHC8***      5.53       0.026           NM_013373
  ***CCL3L3***                     8.67                             0.023           NM_001001437      ***C20orf152***   5.50       0.043           ENST00000349339
  ***CLEC4E***                     8.66                             0.003           NM_014358         ***DCN***         5.47       0.003           NM_133504
  ***CUTC***                       8.64                             0.004           NM_015960         ***SYT4***        5.31       0.029           NM_020783
  ***OAZ1***                       8.62                             0.004           NM_004152         ***PTF1A***       5.28       0.041           NM_178161
  ***RPS8***                       8.44                             0.001           NM_001012         ***FAM153B***     5.27       0.006           ENST00000253490
  ***JTB***                        8.31                             0.004           NM_006694         ***MAGEA6***      5.24       0.001           NM_175868
  ***ISCU***                       8.16                             0.002           NM_213595         ***CPSF1***       5.23       0.010           NM_013291
  ***NPM1***                       8.07                             0.007           NM_199185         ***DCTN1***       5.14       0.015           NM_001135041
  ***FAM96A***                     8.01                             0.003           NM_032231         ***CT45A1***      5.07       0.005           NM_001017417
  ***SMYD2***                      7.97                             0.002           NM_020197         ***CPN1***        4.98       0.005           NM_001308

Top mRNAs differentially expressed with poverty and *P*\<0.05, Fold change \>2 and FDR \<0.1.

Differences in mRNA abundance were also examined in AA males. There were very few mRNAs showing significant changes in abundance with age in AA males ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}). More mRNAs were significantly different comparing individuals above and below poverty ([Supplementary Figure 1](#SD1){ref-type="supplementary-material"}).

Age and poverty pathway analysis
--------------------------------

To gain additional information about the biological pathways that may be regulated by the mRNAs changing in abundance with poverty and age, we performed gene ontology (GO) analysis. In younger individuals, we found enrichment of pathways associated with mitochondrial function and response to DNA damage and stress ([Figure 5A](#f5){ref-type="fig"}). In older individuals, pathways related to chemokine production and development were enriched. In the context of poverty, pathways related to development and differentiation were enriched in individuals living below poverty ([Figure 5B](#f5){ref-type="fig"}). We found that the top pathways enriched among those living above poverty were those implicated in the response to stress, immune stimuli, and viral infection ([Figure 5B](#f5){ref-type="fig"}). This finding is not unexpected because mRNAs increased in abundance in response to social adversity, are part of the inflammatory response cascade, and mRNAs decreased in abundance with social adversity are noted to be related to the innate interferon antiviral response as well as synthesis of antibodies \[[@r27]\].

![**Pathway analysis for age and poverty.** Differentially expressed mRNAs with age and poverty were used for gene ontology (GO) analysis using categories derived from Gene Ontology. Top biological pathways are shown for age (**A**) and poverty (**B**).](aging-11-101823-g005){#f5}

DISCUSSION
==========

Here, we have examined differences in expressed lncRNAs and mRNAs with age and poverty status in both white and AA males. In our initial genome-wide profiling, we found that white males had larger significant differences in expression levels of lncRNAs and mRNAs with poverty and age, as compared to AA males, where these changes were far more modest. This indicates that the influence of age and poverty on gene expression patterns differs between racial groups. It is not clear what drives these differences, but they may correlate with the wide gap in health status and health outcomes between AAs and whites particularly between AA men and white men. AA males living below poverty in the HANDLS cohort, and in other studies, are particularly vulnerable to early mortality compared to their white counterparts and even when compared to AA men who live above the poverty line despite adjustments for various lifestyle cofactors \[[@r21],[@r22]\]. Given this disparity, it is important to examine whether and how gene expression or other genomic factors may act as a biologic transduction pathway for the social determinants of health.

We found altered expression levels in a number of lncRNAs with age and poverty in white males. Although lncRNAs have been studied in the context of aging, in general most studies have focused on a specific lncRNA or on those that relate to various hallmarks of aging. Here, we have performed a comprehensive study of lncRNAs that change in abundance with human age in men whose life expectancy at birth and life span is shorter than women. We also compared these lncRNAs to a growing list of age-associated lncRNAs from the literature. Several of these overlapping lncRNAs were further validated in an expanded cohort of individuals; among these, *GAS5, H19, TERC* and *MEG3* levels were all significantly changed with age ([Figure 3B](#f3){ref-type="fig"}). *GAS5 and MEG3* levels were significantly different with poverty. These data further confirm that these are true age-associated lncRNAs, particularly since these lncRNAs were identified as being aging-associated in other tissues or model systems. Several of these lncRNAs regulate aging processes including telomere function (*TERC*), autophagy (*MEG3*), protein trafficking (*GAS5*), and epigenetic change and proliferation (*H19*) \[[@r13]\]. Investigators have found that many of these lncRNAs participate in regulating age-related disease \[[@r15]\].

In addition to confirming these age-associated lncRNAs, we also identified many novel age- and poverty-associated lncRNAs ([Tables 2, 3](#t2){ref-type="table"}[](#t3){ref-type="table"}). The lncRNAs displaying the largest increases and decreases in abundance were further validated in our expanded cohort; *CTD-3247F14.2 (*LNCipedia: *lnc-EGR3-1)* levels were significantly changed with age, while *AK022914 (DUXAP9),* *KB-1047C11.2 (*LNCipedia: *C8orf37-AS1:1),* and *XLOC_003262* (LNCipedia: *lnc-KY-1*) levels were significantly changed with poverty. These data shed new light on various lncRNAs that may be important biological transducers of stressors related to poverty and age, as well as to the loss of homeostasis that may result from both. Future work lies in determining whether the expression of these lncRNAs is a consequence or contributor to the aging process. Interestingly, we found that the levels of one lncRNA, *RNF157-AS1*, were altered differentially with age in AAs and in whites. It will be interesting in the future to further investigate how this lncRNA expression is altered with age and race.

In summary, we have identified lncRNAs that are altered in abundance with both poverty and age in whites and AAs. As our knowledge of the functional roles of lncRNAs expands, it will be important to determine how these ncRNAs contribute to the aging process and to the biological transduction of social adversity and social determinants that result in health disparities.

MATERIALS AND METHODS
=====================

Clinical participants
---------------------

Participants were chosen from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) study of the National Institute on Aging Intramural Research Program, National Institutes of Health (NIH). The study has been approved by the Institutional Review Board of the National Institute of Environmental Health Sciences, NIH. All participants provided written informed consent. HANDLS is a Baltimore, Maryland based longitudinal epidemiologic study focused on examining the interaction of race and socioeconomic status on aging and age-related health disparities \[[@r37]\]. A sub-cohort of young (\~30 yrs) and old (\~64 yrs) white or African American (AA) males above or below poverty were chosen for the microarray (n=8/group) ([Table 1](#t1){ref-type="table"}). An expanded cohort of white males above and below poverty were chosen for RT-qPCR validation (n=20/group; [Table 1](#t1){ref-type="table"}). Below poverty was designated if the self-reported household income was below 125% of the 2004 Health and Human Services Poverty Guidelines at baseline recruitment.

PBMCs
-----

Fasting blood samples are obtained from participants in the morning and collected in 8-ml Vacutainer® heparinized vials (BD, Franklin Lakes, NJ). Peripheral blood mononuclear cells were isolated within 3 hours of phlebotomy as detailed previously \[[@r4]\]. After isolation, PBMCs are aliquoted and stored at -80^o^C.

RNA isolation and microarray
----------------------------

Total RNA from PBMCs was isolated using TRIzol™ according to manufacturer's instructions. RNA quality and quantity were analyzed using a NanoDrop ND-1000 spectrophotometer and standard denaturing agarose gel electrophoresis.

lncRNA and mRNA microarrays were performed by Arraystar Inc. The Arraystar Human LncRNA Microarray V3.0 contains lncRNAs identified through public transcriptome databases (Refseq, UCSC knowngenes, Gencode, etc), as well as from the literature. In brief, sample preparation and microarray hybridization were performed according to the Agilent One-Color Microarray-Based Gene Expression Analysis protocol (Agilent Technology) with minor modifications. mRNA was purified from total RNA after removal of rRNA (mRNA-ONLY™ Eukaryotic mRNA Isolation Kit, Epicentre). Subsequently, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3' bias utilizing a random priming method (Arraystar Flash RNA Labeling Kit, Arraystar). The labeled cRNAs were hybridized onto the Human LncRNA Array v3.0 (8 x 60K, Arraystar). After washing and fixing of the slides, the arrays were scanned by the Agilent Scanner G2505C.

Acquired array images were analyzed using the Agilent Feature Extraction software (version 11.0.1.1). Quantile normalization and subsequent data processing were performed using the GeneSpring GX v12.0 software package (Agilent Technologies). After quantile normalization of the raw data, ComBat was used to adjust batch effects. After normalization of the raw data, lncRNAs and mRNAs that at least 8 out of 16 samples have flags in present or marginal were chosen for further data analysis. Differentially expressed lncRNAs and mRNAs with statistical significance with Fold Change \>= 2.0, *P* value \<= 0.05 were identified through Volcano Plot filtering between two groups. All significantly changed lncRNAs are listed in [Supplementary Table 1](#SD2){ref-type="supplementary-material"}, [Supplementary Table 2](#SD3){ref-type="supplementary-material"}, [Supplementary Table 3](#SD4){ref-type="supplementary-material"}, [Supplementary Table 4](#SD5){ref-type="supplementary-material"} and mRNAs in [Supplementary Table 6](#SD7){ref-type="supplementary-material"}, [Supplementary Table 7](#SD8){ref-type="supplementary-material"}, [Supplementary Table 8](#SD9){ref-type="supplementary-material"}, [Supplementary Table 9](#SD10){ref-type="supplementary-material"}. Differentially expressed mRNAs were used for gene ontology (GO) analysis using categories derived from Gene Ontology (<http://www.geneontology.org>). Biological pathways are shown. Fisher's exact test was used to calculate significance and *P* value denotes the significance of GO term enrichment in the differentially expressed genes. Microarray data can be accessed at GEO (Accession Number: GSE123500).

RT-qPCR
-------

Cryopreserved PBMCs were thawed quickly and washed with PBS. Total RNA was isolated using TRIzol™ according to manufacturer's instructions with an inclusion of a DNase treatment step. RNA quality and quantity were analyzed using a NanoDrop 2000c. RNA was reverse transcribed using random hexamers and reverse transcriptase (Invitrogen). RT-qPCR was performed using SYBR green master mix and lncRNA specific primers. LncRNA primer sequences were designed using NCBI reference sequences or sequences from LNCipedia ([www.lncipedia.org](http://www.lncipedia.org)). Primer sequences and detailed information are listed in [Supplementary Table 10](#SD11){ref-type="supplementary-material"}. In some cases, the LNCipedia nomenclature differs from the nomenclature used here and these alternative names are also listed in the text and in Supplementary Table 10. *NEAT1* and *MEG3* primers were described previously \[[@r38],[@r39]\]. *GAS5* has 29 different transcripts and primers were designed using sequences from microarray. Similar data was observed for transcript variants *GAS5_019, GAS5_24* and *GAS5_026* and data only from *GAS5_019* is shown. For other lncRNAs with multiple variants, primers were designed against exons that overlapping between the variants. Reactions were run on an Applied Biosystems 7500 Real-Time PCR System using default settings. lncRNA expression was normalized to an average of *HPRT* and *UBC*. Previously we have found that these mRNAs are least variable for aging studies in PBMCs \[[@r40]\]. lncRNA levels were examined for Gaussian distribution by measuring kurtosis and skewness and outliers for each lncRNA were excluded from the analysis using Grubb's test with an alpha of 0.05.
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